What is the share price of Indo Us Bio-Tech Ltd (INDOUS) today?
The share price of INDOUS as on 28th March 2025 is ₹148.96. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Indo Us Bio-Tech Ltd (INDOUS) share?
The past returns of Indo Us Bio-Tech Ltd (INDOUS) share are- Past 1 week: -6.11%
- Past 1 month: -23.49%
- Past 3 months: -56.26%
- Past 6 months: -49.39%
- Past 1 year: -32.89%
- Past 3 years: 358.34%
- Past 5 years: 600.99%
What are the peers or stocks similar to Indo Us Bio-Tech Ltd (INDOUS)?
The peers or stocks similar to Indo Us Bio-Tech Ltd (INDOUS) include:What is the market cap of Indo Us Bio-Tech Ltd (INDOUS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indo Us Bio-Tech Ltd (INDOUS) is ₹325.42 Cr as of 28th March 2025.What is the 52 week high and low of Indo Us Bio-Tech Ltd (INDOUS) share?
The 52-week high of Indo Us Bio-Tech Ltd (INDOUS) is ₹388.40 and the 52-week low is ₹148.96.What is the PE and PB ratio of Indo Us Bio-Tech Ltd (INDOUS) stock?
The P/E (price-to-earnings) ratio of Indo Us Bio-Tech Ltd (INDOUS) is 39.45. The P/B (price-to-book) ratio is 5.19.Which sector does Indo Us Bio-Tech Ltd (INDOUS) belong to?
Indo Us Bio-Tech Ltd (INDOUS) belongs to the Consumer Staples sector & Agro Products sub-sector.How to buy Indo Us Bio-Tech Ltd (INDOUS) shares?
You can directly buy Indo Us Bio-Tech Ltd (INDOUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Indo Us Bio-Tech Ltd
INDOUS Share Price
148.965.00% (-7.84)
INDOUS Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
INDOUS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 19.38 | 5.19 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.89 | 8.99 | 1.58% |
INDOUS Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INDOUS Company Profile
Indo US Bio-Tech Ltd specializes in the research, production, and marketing of hybrid and open-pollinated agricultural seeds, serving local farmers with diverse crop varieties.
INDOUS Similar Stocks (Peers)
Compare with peersGODREJAGRO
PE Ratio
41.00
1Y Return
54.76%
Buy Reco %
80.00
PE Ratio
13.67
1Y Return
36.12%
Buy Reco %
100.00
PE Ratio
74.08
1Y Return
16.89%
Buy Reco %
—
SANSTAR
PE Ratio
24.41
1Y Return
24.08%
Buy Reco %
—
CROPSTER
PE Ratio
147.49
1Y Return
34.44%
Buy Reco %
—
INDOUS Forecasts
Price
Revenue
Earnings
INDOUS Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeINDOUS Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeINDOUS Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeINDOUS
Income
Balance Sheet
Cash Flow
Annual Normal View
INDOUS Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19.15 | 24.58 | 29.62 | 35.38 | 39.77 | 40.13 | 50.23 | 61.76 | 73.16 | 108.69 | ||||||||||
Raw Materials | 17.78 | 20.12 | 24.16 | 26.71 | 2.81 | 2.46 | 2.18 | 5.27 | 5.88 | 88.77 | ||||||||||
| Power & Fuel Cost | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.07 | 0.07 | 0.14 | 0.18 | |||||||||||
| Employee Cost | 0.38 | 0.36 | 0.38 | 0.27 | 0.35 | 0.34 | 0.48 | 1.19 | 0.92 | |||||||||||
| Selling & Administrative Expenses | 1.49 | 1.52 | 1.54 | 3.40 | 3.04 | 5.59 | 4.61 | 3.68 | 7.61 | |||||||||||
| Operating & Other expenses | -1.13 | 1.24 | 0.57 | 1.51 | 29.57 | 26.10 | 35.77 | 42.08 | 47.44 | |||||||||||
EBITDA | 0.61 | 1.32 | 2.94 | 3.46 | 3.97 | 5.57 | 7.12 | 9.40 | 11.13 | 19.92 | ||||||||||
| Depreciation/Amortization | 0.14 | 0.15 | 0.17 | 0.25 | 0.23 | 0.26 | 0.44 | 0.83 | 0.80 | 0.93 | ||||||||||
| PBIT | 0.47 | 1.17 | 2.77 | 3.21 | 3.74 | 5.31 | 6.68 | 8.57 | 10.33 | 18.99 | ||||||||||
| Interest & Other Items | 0.22 | 0.64 | 0.72 | 0.40 | 0.88 | 1.18 | 1.20 | 1.20 | 1.52 | 1.96 | ||||||||||
| PBT | 0.25 | 0.53 | 2.05 | 2.81 | 2.86 | 4.13 | 5.48 | 7.37 | 8.81 | 17.03 | ||||||||||
| Taxes & Other Items | -0.12 | 0.13 | 0.59 | 0.72 | 0.33 | -0.97 | 0.25 | 0.15 | 0.56 | 0.24 | ||||||||||
| Net Income | 0.37 | 0.40 | 1.46 | 2.09 | 2.53 | 5.10 | 5.23 | 7.22 | 8.25 | 16.79 | ||||||||||
| EPS | 0.28 | 0.30 | 0.66 | 0.92 | 1.74 | 3.50 | 2.04 | 1.88 | 2.74 | 8.37 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
INDOUS Company Updates
FY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFINDOUS Past Performance & Peer Comparison
Comparing 3 stocks from
Consumer StaplesAgro Products
Compare valuation on Screener
Consumer StaplesAgro Products
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indo Us Bio-Tech Ltd | 39.45 | 5.19 | — |
| Godrej Agrovet Ltd | 41.00 | 5.05 | 1.30% |
| Gujarat Ambuja Exports Ltd | 13.67 | 1.70 | 0.34% |
| Jubilant Agri and Consumer Products Ltd | 74.08 | 8.27 | — |
INDOUS Stock Price Comparison
Compare INDOUS with any stock or ETFCompare INDOUS with any stock or ETF
INDOUS
INDOUS Shareholdings
INDOUS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDOUS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDOUS Shareholding Pattern
INDOUS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDOUS stock
Looks like this stock is not in any smallcase yet.
INDOUS Events
INDOUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDOUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDOUS Upcoming Dividends
No upcoming dividends are available
INDOUS Past Dividends
Cash Dividend
Ex DateEx DateDec 3, 2024
Interim
Interim | Div/Share: ₹0.25
Dividend/Share
₹0.25
Ex DateEx Date
Dec 3, 2024
Cash Dividend
Ex DateEx DateOct 28, 2021
Interim
Interim | Div/Share: ₹0.25
Dividend/Share
₹0.25
Ex DateEx Date
Oct 28, 2021
INDOUS Stock News & Opinions
Articles & Videos
Earnings
Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales23.5622.11 7 OPM %23.4719.13 - PBDT5.173.94 31 PBT5.013.75 34 NP5.053.68 37 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Indo US Bio-Tech schedules board meeting
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Indo US Bio-Tech Ltd leads gainers in 'B' group
One Mobikwik Systems Ltd, Captain Pipes Ltd, Incredible Industries Ltd and DC Infotech & Communication Ltd are among the other gainers in the BSE's 'B' group today, 26 December 2024.Indo US Bio-Tech Ltd soared 15.32% to Rs 314.95 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 4875 shares were traded on the counter so far as against the average daily volumes of 9989 shares in the past one month. One Mobikwik Systems Ltd surged 13.50% to Rs 691.4. The stock was the second biggest gainer in 'B' group. On the BSE, 35.7 lakh shares were traded on the counter so far as against the average daily volumes of 24.98 lakh shares in the past one month. Captain Pipes Ltd spiked 12.80% to Rs 18.07. The stock was the third biggest gainer in 'B' group. On the BSE, 19.67 lakh shares were traded on the counter so far as against the average daily volumes of 3.2 lakh shares in the past one month. Incredible Industries Ltd jumped 12.61% to Rs 51.8. The stock was the fourth biggest gainer in 'B' group. On the BSE, 22347 shares were traded on the counter so far as against the average daily volumes of 4590 shares in the past one month. DC Infotech & Communication Ltd spurt 10.00% to Rs 381.15. The stock was the fifth biggest gainer in 'B' group. On the BSE, 2912 shares were traded on the counter so far as against the average daily volumes of 2122 shares in the past one month. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Indo Us Bio-Tech fixes record date for interim dividend
Indo Us Bio-Tech has fixed 03 December 2024 as record date for payment of interim dividend for FY 2024-25. The payment will be completed on or before 19 December 2024. Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of Indo US Bio-Tech recommends Interim Dividend
Indo US Bio-Tech announced that the Board of Directors of the Company at its meeting held on 21 November 2024, has recommended a Interim dividend of Rs.0.25 per share (i.e.2.5%), subject to the approval of the shareholders.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Indo US Bio-Tech standalone net profit rises 161.08% in the September 2024 quarter
Net profit of Indo US Bio-Tech rose 161.08% to Rs 4.36 crore in the quarter ended September 2024 as against Rs 1.67 crore during the previous quarter ended September 2023. Sales rose 40.23% to Rs 22.17 crore in the quarter ended September 2024 as against Rs 15.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales22.1715.81 40 OPM %23.1416.45 - PBDT4.632.19 111 PBT4.451.98 125 NP4.361.67 161 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Indo US Bio-Tech revises board meeting date
Indo US Bio-Tech has revised the meeting of the Board of Directors which was scheduled to be held on 16 November 2024. The meeting will now be held on 21 November 2024.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Indo US Bio-Tech to consider Interim Dividend
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 16 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Indo US Bio-Tech announces board meeting date
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Indo US Bio-Tech to conduct AGM
Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 15.64%, vs industry avg of 6.54%
Over the last 5 years, market share increased from 0.18% to 0.2%
Over the last 5 years, net income has grown at a yearly rate of 31.6%, vs industry avg of 3.83%